Tech Center 1600 • Art Units: 1634 1683 1699
This examiner grants 47% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18362013 | SEQUENCE CONVERSION AND SIGNAL AMPLIFIER DNA HAVING ABASIC NUCLEIC ACIDS, AND DETECTION METHODS USING SAME | Non-Final OA | ABBOTT LABORATORIES |
| 18568042 | INTERNAL STANDARD NUCLEIC ACID FOR QUANTIFYING EUKARYOTIC MICROORGANISMS | Non-Final OA | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY |
| 18582159 | Treatment Of Obesity In Subjects Having Variant Nucleic Acid Molecules Encoding Calcitonin Receptor (CALCR) | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 18455954 | NUCLEIC ACID DELIVERY SCAFFOLDS | Non-Final OA | Singular Genomics Systems, Inc. |
| 18034876 | USE OF BRAIN ORGANOIDS AND SINGLE CELL GENOMICS TO UNDERSTAND AND TREAT NEURODEVELOPMENTAL AND NEUROPSYCHIATRIC DISORDERS | Non-Final OA | Massachusetts Institute of Technology |
| 17999137 | PERSONALISED RECOMMENDED DAILY INTAKE FOR NUTRIENTS BASED ON INDIVIDUAL GENETIC RISK SCORES | Final Rejection | SOCIETE DES PRODUITS NESTLE S.A. |
| 18258872 | METHODS FOR PERFORMING MULTIPLEXED REAL-TIME PCR WITH THE USE OF LARGE STOKES SHIFT FLUORESCENT DYES | Non-Final OA | Roche Molecular Systems, Inc. |
| 18291403 | PCR KIT-OF-PARTS, METHOD AND SYSTEM | Non-Final OA | Hewlett-Packard Development Company, L.P. |
| 18403902 | MULTI-OMIC ANALYSIS IN MONODISPERSE DROPLETS | Non-Final OA | ILLUMINA, INC. |
| 18270684 | HIGH-SPATIAL-RESOLUTION EPIGENOMIC PROFILING | Non-Final OA | YALE UNIVERSITY |
| 18168955 | METHODS OF DETERMINING COVID-19 MORTALITY RISK | Non-Final OA | WASHINGTON UNIVERSITY |
| 18340581 | COMPOSITIONS AND METHODS FOR HIGHLY SENSITIVE DETECTION OF TARGET SEQUENCES IN MULTIPLEX REACTIONS | Non-Final OA | Life Technologies Corporation |
| 17787433 | NOVEL DRUGGABLE TARGETS FOR THE TREATMENT OF INFLAMMATORY DISEASES SUCH AS SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND METHODS FOR DIAGNOSIS AND TREATMENT USING THE SAME | Final Rejection | THE CHILDREN'S HOSPITAL OF PHILADELPHIA |
| 17906123 | THERAPEUTIC METHODS FOR THE TREATMENT OF SUBJECTS WITH RISK ALELLES IN IL33 | Final Rejection | MedImmune Limited |
| 18572107 | UNIT-DNA COMPOSITION FOR SPATIAL BARCODING AND SEQUENCING | Non-Final OA | Miltenyi Biotec B.V. & Co. KG |
| 18368415 | METHODS AND COMPOSITIONS FOR SINGLE-STRANDED NUCLEIC ACID LADDERS BY GUIDED CLEAVAGE | Non-Final OA | Revvity Health Sciences, Inc. |
| 17905021 | METHODS AND KITS FOR TREATING OR DIAGNOSING CANNABINOID HYPEREMESIS SYNDROME | Non-Final OA | CReDO Science, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy